PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totaling 45,319 shares, a decline of 55.2% from the May 31st total of 101,221 shares. Based on an average daily volume of 82 shares, the short-interest ratio is presently 552.7 days.
PureTech Health Price Performance
OTCMKTS:PTCHF remained flat at $1.70 during trading hours on Tuesday. The company has a 50 day simple moving average of $1.75 and a two-hundred day simple moving average of $1.70. PureTech Health has a 1-year low of $1.55 and a 1-year high of $1.92.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Featured Stories
- Five stocks we like better than PureTech Health
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
